TERPS Trial for de Novo Oligometastic Prostate Cancer

NCT05223803 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Oligometastatic Disease

Interventions

RADIATION: Prostate radiation (XRT)
DRUG: Systemic Therapy
RADIATION: Stereotactic ablative radiation therapy (SABR)

Sponsor

University of Maryland, Baltimore